fda tirzepatide injection shortage resolved oct 2 2024 Zepbound ends, impacts patients, compounding pharmacies Compounders protest as FDA removes

doi: 10.1111/j.1365-2672.2009.04294.x 225 StecchiniMLDel TorreMMunariM

However, chest discomfort can occasionally be reported by patients taking tirzepatide through several potential mechanisms

We mitigate this by titrating slowly and prescribing anti-nausea medication (Zofran) if needed

If your request is denied, don't give up

This may explain why weight reduction at 3 months was evident in both the IGB-only group and the IGB + semaglutide group, yet this difference was not found to be significant until 6 and 12 months of therapy

Any patient who has diabetes, kidney disease, or has had a kidney transplant is eligible based on medical need